Serum from rabbit orally administered cobra venom inhibits growth of implanted hepatocellular carcinoma cells in mice

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

287

HTML

2591

Figures (1-2)

261

Tables (1-2)

191

Sum=3330

Nov 15, 2003 (publication date) through Feb 8, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Nov 15, 2003; 9(11): 2441-2444
Published online Nov 15, 2003. doi: 10.3748/wjg.v9.i11.2441

Table 2 Apoptotic rates (AR) of implanted tumor in SRCV treated mice determined by TUNEL and FCM methods (n = 8, ¯x ± s)

^bP < 0.01 vs control group.

Citation: Sun P, Ren XD, Zhang HW, Li XH, Cai SH, Ye KH, Li XK. Serum from rabbit orally administered cobra venom inhibits growth of implanted hepatocellular carcinoma cells in mice. World J Gastroenterol 2003; 9(11): 2441-2444
URL: https://www.wjgnet.com/1007-9327/full/v9/i11/2441.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i11.2441